Appointment of Joint Lead Investment Managers

RNS Number : 2914S

Intl. Biotechnology Trust PLC

15 March 2021

 

15 March 2021

INTERNATIONAL BIOTECHNOLOGY TRUST PLC

("IBT" or the "Company")

APPOINTMENT OF JOINT LEAD INVESTMENT MANAGERS

The Board of International Biotechnology Trust (the "Company") and SV Health Investors announce that Carl Harald Janson has decided to step back from his role as Lead Investment Manager after seven successful years at the Company's helm.

Lead responsibility for portfolio management will transition to Ailsa Craig and Marek Poszepczynski and the Board has approved them as joint Lead Investment Managers. Following a handover period, Carl Harald will remain as a Senior Adviser to SV Health Investors.  Kate Bingham will remain the Investment Manager of the Company's unquoted portfolio.

Ailsa and Marek have played key roles working alongside Carl Harald in the investment management team of the Company, and both have many years' experience in the biotechnology and healthcare industry and are scientifically trained. Ailsa has been an investment manager at SV Health Investors for 15 years, having previously worked as a healthcare research analyst. Marek joined SV Health Investors in 2014 as an investment manager, having previously worked for a decade in business development within the biotech industry, structuring and creating M&A transactions and IPOs as well as founding and managing several biotech companies.

Jim Horsburgh, Chairman, commented: "We thank Carl Harald for the pivotal role he has played over the past seven years leading International Biotechnology Trust to an all-time high in NAV terms in 2020, and wish him well for the future. Ailsa and Marek are extremely capable and long-standing core members of our investment team and we are confident that they will continue to deliver strong returns to shareholders."

For further information contact:

Broker - Numis

Nathan Brown  [phone] / [phone]

Vicki Paine  [phone] / [phone]

Company Secretary - Link Company Matters

Claire Jackson   [phone]

LEI: 213800N1QUJ744P76D11

 

END

 

 

MSCLELFFFXLZBBL